Table 1: Major polymorphic variants found in this study in patients with psoriasis (PsO) and psoriatic arthritis (PsA).

MarkerPsO Controls valuesPsA Controls values

0625 (50%)19 (17%)<0.00001a62 (56.4%)19 (17%)<0.00001e
MICA-A9 15 (30%)33 (30%)NS66 (60%)33 (30%)<0.00001f
MICA-A5.1 18 (36%)44 (40%)NS38 (34.5%)44 (40%)NS
MICB-CA20 5 (10%)9 (8.1%)NS15 (13.6%)9 (8.1%)NS
0715 (30%)33 (30%)NS43 (39.1%)33 (30%)NS
275 (10%)8 (7.3%)NS36 (32.7%)8 (7.3%)0.001g
C1_4_4 (384) 28 (56%)25 (23%)0.0001b60 (54.5%)25 (23%)0.0001h
OTF3 Hind3 42 (84%)66 (60%)0.0033c73 (66.4%)66 (60%)NS
HCR (Pg8) 31 (62%)28 (25.5%)<0.00001d37 (33.6%)28 (25.5%)NS

OR 4.8 (2.3–10.1).
OR 4.3 (2.1–8.8).
OR 3.5 (1.5–8.01).
OR 4.8 (2.3–9.7).
OR 6.18 (3.32–11.51).
OR 3.5 (2.0–6.12).
OR 5.9 (2.6–13.4).
OR 4.3 (2.2–8.4).
There was linkage disequilibrium between 06 and C1_4_4 ( ).